Preview

International journal of Innovative Medicine

Advanced search

The Scientific journal "International journal of Innovative Medicine" about the latest achievements of world medicine. The articles contain information about innovative technologies, ongoing research, and achievements in various fields of medicine. The journal aims to unite different groups of specialists to increase the level of scientific knowledge and improve the exchange of information.

The journal is intended for large medical centers, for doctors of all specialties, health care organizers and researchers of medical and educational organizations. Scientific editors and authors of the journal «International journal of innovative medicine» (IJIM) are leading specialists in their specialties. The journal publishes original articles with the results of original and fundamental studies with clinical significance, modern analytical reviews, as well as materials of clinical cases. Thematic issues of the journal are edited by leading experts in the field of medicine.

The editorial board carries out work on reviewing and selection of materials for each issue thematically. Attracts influential scientists in the field of expertise of manuscripts and the identification of important scientific works for publication. All publications of the journal are assigned the DOI code by the international registration Agency Crossref. The journal is included in the List of the leading peer-reviewed scientific journals of the HAC of the Russian Federation, in the scientific citation index (RSCI), in the open access in the Electronic scientific library, as well as placed and uploaded in libraries and databases. The journal corresponds to the codes of groups of scientific specialties: Clinical medicine, Preventive medicine, Medical and biological sciences.

Current issue

No 1 (2025)
View or download the full issue PDF
4-14 52
Abstract

Background/objectives: mandibular fractures and their purulent-inflammatory complications represent significant challenges in maxillofacial surgery.

This study aims to evaluate the effectiveness of a comprehensive pathogenetic therapy in optimizing treatment outcomes for such conditions. Special attention is given to microbial contamination, oral and systemic dysbiosis, and their impact on the development of post-traumatic complications.

Methods: A total of 231 patients with mandibular fractures were analyzed. The patients were divided into two groups: one received traditional therapy (Furacilin, Chlorhexidine, Bifidumbacterin, and standard surgical fixation), while the other underwent a specialized treatment regimen, including Serrata, Sextophag, Azithromycin, and Florbiolact. Microbiological studies were conducted to determine microbial sensitivity to therapeutic agents. Radiological diagnostic methods, including computed tomography (CT) and magnetic resonance imaging (MRI), were used to assess fracture characteristics and treatment dynamics.

Results: the specialized treatment group demonstrated a significant reduction in purulent-inflammatory complications, such as osteomyelitis and phlegmons, compared to the traditional therapy group. By day 21, dysbiosis in the oral cavity was nearly eliminated, and indicators of local immunity (e.g., lysozyme levels and secretory immunoglobulin A) showed substantial improvement. In addition, patients receiving specialized therapy experienced faster resolution of pain and inflammation, with a decrease in temporary disability duration.

Conclusions: the findings confirm that the use of advanced pathogenetic therapy, which combines antimicrobial, probiotic, and enzymatic agents, enhances the treatment of mandibular fractures and reduces the risk of complications. This integrated approach emphasizes the importance of targeted and multidisciplinary strategies in maxillofacial surgery for achieving optimal clinical outcomes. 

15-18 87
Abstract

Diabetic neuropathy is one of the most severe complications of diabetes mellitus, significantly impairing patients’ quality of life. This article presents current approaches to the diagnosis and treatment of this condition, including the application of innovative technologies such as gene and cell therapy, nanotechnology, and artificial intelligence. Special emphasis is placed on prevention and the interdisciplinary approach aimed at improving patient outcomes. 

Announcements

2024-07-08

Город с высоким качеством жизни: лауреат Нобелевской премии мира оценил инфраструктуру Москвы

Москва — один из мировых флагманов интеграции условий зеленой экономики и устойчивого развития. Знаковые примеры технологического лидерства столицы России, которыми Москва может поделиться с другими странами, обсудили в рамках пресс-конференции, посвященной проведению Форума будущего БРИКС. Облачные города.

«Москва инвестирует в инфраструктуру — рельсовую, автомобильную, метро, зеленые пространства — и это прекрасно. Я наслаждаюсь высоким качеством воздуха в Москве, высоким качеством жизни. Это важный урок и пример, для тех, кто занимается городским планированием», отметил почетный председатель Форума будущего БРИКС. Облачные города,  лауреат  Нобелевской премии мира Рае Квон Чунг.

Программный директор Форума Евгений Кузнецов рассказал о лучших практиках столицы, которые могли бы быть масштабированы в странах БРИКС. Среди них: система контроля за водителями, чтобы они не отвлекались и не засыпали эту практику уже позаимствовали бразильские города, 15-минутная доставка еды, роботы-доставщики и беспилотные такси.

Еще одна столичная инновация коснулась строительства и формирования комфортной среды и здорового образа жизни в городе.

«Много решений сейчас в Москве создаются и на уровне градостроения, даже с опережением рынка. Появилось множество проектов с умными зданиями, к которым даже не очень-то готовы потребители в других странах. То есть, в России уже вырабатывается более высокая требовательность к качеству таких интеллектуальных решений», — поделился Евгений Кузнецов.

Форум будущего БРИКС. Облачные города состоится в Москве 18-19 сентября 2024. Он станет площадкой для диалога бизнеса, государства и жителей и позволит отобрать, а затем интегрировать лучшие практики в жизнь городов.

More Announcements...


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.